Healthcare
Thursday, September 15, 2016
BRIEF-Mimedx urges FDA to reconsider draft guidances
* Mimedx says continues to believe that its marketing of
its products as section 361 hct/ps is consistent with applicable
statutes and regulations
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment